Amazing value implied for NEU. He puts the value of Trof to Acadia right now at $US4.66 per share based on the US market alone rising to $US7.77 upon FDA approval.
Consider
- double digit royalties
- sale of ROW right
- double digit ROW royalties
- share of the sale of the Voucher
- milestone payments
- the almost forgotten Fragile x
- entire potential value of the other molecule.
No wonder Karst Peak and Midford are backing up the truck.
Acadia - Catalysts Stacking, page-4
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.39 |
Change
0.000(0.00%) |
Mkt cap ! $2.478B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6 | $20.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.44 | 108 | 3 |
View Market Depth
| Last trade - 09.56am 31/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |
Day chart unavailable